Understand the key differences between heart failure and stroke clinical trials and research opportunities
Affects ~1 million in the UK. SGLT2 inhibitors, ARNI, and device therapies are major trial focus areas. Both HFrEF and HFpEF have active research.
~100,000 strokes per year in the UK. Trials focus on acute interventions (thrombectomy windows), secondary prevention, and rehabilitation approaches.
Heart failure trials are predominantly pharmacological. Stroke trials span acute intervention, prevention, and recovery — wider scope but harder endpoints.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.